Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

Various studies have emphasized an immunodepression state observed at the tumour site. To reverse this defect and based upon animal studies, we initiated a phase I clinical trial of gene therapy in which various doses of xenogeneic monkey fibroblasts (Vero cells) genetically engineered to produce hu...

詳細記述

保存先:
書誌詳細
主要な著者: Tartour, E, Mehtali, M, Sastre-Garau, X, Joyeux, I, Mathiot, C, Pleau, J M, Squiban, P, Rochlitz, C, Courtney, M, Jantscheff, P, Herrmann, R, Pouillart, P, Fridman, W H, Dorval, T
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2000
主題:
Regular Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363414/
https://ncbi.nlm.nih.gov/pubmed/11076653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1492
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料